Literature DB >> 19365123

FOXP1 expression predicts polymorphic histology and poor prognosis in gastric mucosa-associated lymphoid tissue lymphomas.

Shao-liang Han1, Xiu-ling Wu, Li Wan, Qi-qiang Zeng, Jun-lin Li, Zhi Liu.   

Abstract

UNLABELLED: RATIONALE/HYPOTHESIS: Forkhead box protein P1 (FOXP1) is one member of the forkhead box protein P (FOXP) subfamily, which are transcription factors that mediate signaling and affect gene regulation, and elevated expression of FOXP1 has been reported to correlate with poor prognosis of diffuse large B-cell lymphoma (DLBCL). Recently, it was also found that FOXP1 expression occurs in mucosa-associated lymphoid tissue (MALT) lymphomas.
OBJECTIVE: FOXP1 expression and its relationship to morphology and prognosis in a series of 43 gastric MALT lymphomas were investigated retrospectively.
FINDINGS: The FOXP1 nuclear expression (44.2%, 19/43) of tumors between mono- and polymorphic histology (4 of 26 [15.4%] vs. 15 of 17 [88.2%]) was significantly different (p < 0.001). All 14 relapsed tumors after operation featured strong nuclear FOXP1 positivity. A significantly shorter cumulative 10-year survival (52.6%,10/19) was found in high FOXP1 expression patients, compared with patients with negative expression (83.3%, 20/24) (p < 0.01). Also, the cumulative 10-year survival rate (30.8%, 4/13) for stage IIE+IV was significantly shorter than that (83.3%, 25/30) in stage I+II (p < 0.01). Moreover, high FOXP1 expression and advanced stage IIE+IV were independent prognostic factors in multivariate Cox regression analysis.
CONCLUSIONS: Our results show that FOXP1 expression is correlated with morphic histology, and FOXP1 and clinical staging appear to be independent prognostic factors in gastric MALT lymphomas. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19365123     DOI: 10.1159/000212058

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  9 in total

Review 1.  Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development.

Authors:  Xavier Sagaert; Eric Van Cutsem; Gert De Hertogh; Karel Geboes; Thomas Tousseyn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-04       Impact factor: 46.802

2.  Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type.

Authors:  Linzhu Zhai; Yuanyuan Zhao; Sheng Ye; He Huang; Ying Tian; Qiuliang Wu; Hanliang Lin; Tongyu Lin
Journal:  Tumour Biol       Date:  2011-06-10

3.  New developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-09-26       Impact factor: 0.196

4.  Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL.

Authors:  Miaoxia He; Li Gao; Shimin Zhang; Liyang Tao; Jianjun Wang; Jianmin Yang; Minghua Zhu
Journal:  Gastric Cancer       Date:  2013-11-14       Impact factor: 7.370

5.  Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1.

Authors:  Leila Rouhigharabaei; Julio Finalet Ferreiro; Thomas Tousseyn; Jo-Anne van der Krogt; Natalie Put; Eugenia Haralambieva; Carlos Graux; Brigitte Maes; Carmen Vicente; Peter Vandenberghe; Jan Cools; Iwona Wlodarska
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

Review 6.  Prognostic value of decreased FOXP1 protein expression in various tumors: a systematic review and meta-analysis.

Authors:  Jian Xiao; Bixiu He; Yong Zou; Xi Chen; Xiaoxiao Lu; Mingxuan Xie; Wei Li; Shuya He; Shaojin You; Qiong Chen
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

Review 7.  Molecular networks of FOXP family: dual biologic functions, interplay with other molecules and clinical implications in cancer progression.

Authors:  Ju-Ha Kim; Jisung Hwang; Ji Hoon Jung; Hyo-Jung Lee; Dae Young Lee; Sung-Hoon Kim
Journal:  Mol Cancer       Date:  2019-12-09       Impact factor: 27.401

Review 8.  Neglected, yet significant role of FOXP1 in T-cell quiescence, differentiation and exhaustion.

Authors:  Yaroslav Kaminskiy; Varvara Kuznetsova; Anna Kudriaeva; Ekaterina Zmievskaya; Emil Bulatov
Journal:  Front Immunol       Date:  2022-10-04       Impact factor: 8.786

9.  Downregulation of FOXP1 Inhibits Cell Proliferation in Hepatocellular Carcinoma by Inducing G1/S Phase Cell Cycle Arrest.

Authors:  Xin Wang; Ji Sun; Meiling Cui; Fangyu Zhao; Chao Ge; Taoyang Chen; Ming Yao; Jinjun Li
Journal:  Int J Mol Sci       Date:  2016-09-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.